By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioCardia, Inc. 

384 Oyster Point Boulevard, #4

South San Francisco  California  94080  U.S.A.
Phone: 650-624-0120 Fax: 650-624-0125


SEARCH JOBS


Industry
Biotechnology






Company News
BioCardia Release: CardiAMP Pivotal Heart Failure Trial Initiated At Two US Centers 12/29/2016 8:17:04 AM
BioCardia Receives Another U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III CardiAMP Program 12/27/2016 10:38:36 AM
BioCardia Receives U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III Cardiamp Program 12/14/2016 7:34:08 AM
BioCardia Closes Merger With Tiger X Medical 10/24/2016 12:54:37 PM
BioCardia Signs Merger Agreement With Tiger X Medical Secures Funding To Support Further Development Of Cardiamp Cell Therapy System For The Treatment Of Heart Failure 8/23/2016 10:44:15 AM
BioCardia Announces Two Presentations Related To CardiAMP Cell Therapy At Cardiovascular Research Technologies In Washington, DC 2/22/2016 2:17:36 PM
BioCardia Announces Upcoming Cell Therapy Presentations At Cardiovascular Research Technologies Conference 1/29/2016 8:34:14 AM
BioCardia To Present At 2015 Stem Cell Meeting On The Mesa 10/6/2015 9:26:26 AM
BioCardia Seeks $58 Million IPO 6/17/2015 11:28:40 AM
BioCardia Announces FDA Acceptance Of Phase 3 Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy For Heart Failure Patients 11/11/2014 11:16:25 AM
123
//-->